Nouvex Antimicrobial
Easily Integrated
into the manufacturing processes of paper, plastics, glass, coatings, and textiles
Versatile
consumer products, building materials, healthcare products and more
Previous
Next

Nouvex™ Antimicrobial

A Novel Approach to Improve Cleanliness

Nouvex™ antimicrobial technology is a new approach to antimicrobial science. The Poly Group team can help you deploy new antimicrobial solutions that use our Nouvex™ product. Nouvex™ is a clear choice that beats out legacy broad spectrum organic, inorganic and organometallic technologies.

Nouvex™ will be the global leader in antimicrobial protection surpassing legacy solutions. We can help you with the latest technologies to incorporate Nouvex™ into consumer, commercial, textiles, building materials, healthcare products and more.

Bacteria & viruses are a serious health challenge

Today’s antimicrobials have limited effectiveness, encourage bacterial resistance, often have high toxicity, and are costly to produce.
New Approach
Poly Group News

Poly Group Partners for New Antimicrobial Material Options

WEST LAFAYETTE, Ind. – Royer Corp. and Poly Group LLC finalized an exclusive partnership June 22 that results in the manufacture of antimicrobial custom plastic injection molded parts in Madison, Indiana. Nouvex antimicrobial technology was discovered at Purdue University by a group led by Jeffrey Youngblood, a professor in Purdue’s School of Materials Engineering. Poly

Read More »
Poly Group News

Solving Pandemic Challenges

A Purdue-licensed discovery is now available to a world that so desperately needs its protecting power. Indiana-company and global licensee Poly Group LLC has branded its innovative product as Nouvex™. Put simply, Nouvex is a polymeric family of materials that protects surfaces and is scientifically proven to have antimicrobial, antiviral, and antifungal effects, while also

Read More »
Petri dish with bacterial colonies
Poly Group News

Healthcare Associated Infections Focus

1 in 31 hospital patients has at least one healthcare-associated infection (HAI) on any given day. The 2018 National and State HAI Progress Report provides data on central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), surgical site infections (SSIs), methicillin-resistant Staphylococcus aureus (MRSA) bloodstream events, and Clostridioides difficile (C. difficile)

Read More »